Visual Universitätsmedizin Mainz

Fachveranstaltungen und Fort- und Weiterbildungen

Fachveranstaltung FZI-Seminar: Yvette van Kooyk, Amsterdam: "Nanotechnology for the design of dendrtic cell targeting cancer vaccines"

Veranstalter: Research Center for Immunotherapy (FZI)

    Yvette van Kooyk's work combines basic research to a translational setting aimed to aimed to identify glycans as DC targeting strategy to improve anti-tumor as well as glycans that inhibit inflammatory responses such as in auto-immunity. (For more information you find the CV of Prof. van Kooyk below.)

    After the seminar we offer you a wine tasting by the Weingut Lindenhof (Stenner) from Mainz Hechtsheim.

    CV of Prof. van Kooyk:

    1993 Phd (cum laude) at the Department of Immunology at the Netherlands Cancer Institute (University of Amsterdam): Lymphocyte adhesion mediated by integrins

    1993 -1996 PostDoc of Prof. Carl Figdor at the department of Tumor Immunology, University Hospital St Radboud Nijmegen: integrin activation and adhesion functions of Dendritic cells

    2000 Aspasia grant (discovery of the innate receptor DC-SIGN on DC)

    2000 Associate Professor position at Radboud University Nijmegen.

    2001 Prof. van Kooyk transferred with her research group to the VUmc in Amsterdam and was appointed Professor in Molecular Cell Biology, and group leader of the research group 'Dendritic Cell Biology‘.

    She holds the position of program leader 'Immunology'of the Research Institute Oncology and Immunology (CCA/V-ICI) of the Vumc.

    2001 Pioneer Grant: functional glycomics, a field neglected by immunologist, which focuses on the understanding how the exposed glycans on glycoproteins/lipids on pathogens or host cells are instrumental for the functional activity and communication of immune cells, in particular Dendritic Cells. Moreover this discovery set the stage of a whole new field that led to new concepts on pathogen interactions through C-type lectin receptor, that modify Dendritic cell responses.

    Yvette van Kooyk is cofounder of the biotech startup DC4U that focuses on bringing glycan based diagnostics and therapeutics that interfere with DC function into the clinic.


    more info:



scientists and students

Datum Thursday 7. May 2015
Uhrzeit 17:15 - 19:15 Uhr

UMC, Langenbeckstr. 1, Mainz, Building 706, lecture hall


Yvette van Kooyk, Amsterdam

Fortbildungspunkte 1 Punkt (Kat. A) Ärztekammer Rheinhessen; 0.1 CP TransMed

Doreen Nothmann
Scientific Coordinator
Research Center for Immunotherapy (FZI)

of the Johannes Gutenberg University Mainz
Langenbeckstrasse 1
Building 708
D-55131 Mainz

Phone:+49 6131 17 8114
Fax:    +49 6131 17 6202

Downloads Aushang_FZI-Seminar07052015.pdf